Global Pharmaceutical Excipients Market Size By Type (Cellulose and Derivatives, Starch and Derivatives), By Application (Preparation Stability Auxiliary Material, Solid Preparation Accessories), By R...

The Global Pharmaceutical Excipients Market was valued at USD 9.1 billion in 2023 and is projected to reach USD 14.6 billion by 2031, growing at a CAGR of 6.1% during the forecast period of 2023–2031. This growth is driven by the escalating demand for functional excipients in innovative drug formulations, the increasing adoption of biologics, and rising investments in pharmaceutical R&D. Pharmaceutical excipients are essential for enhancing drug solubility, stability, and bioavailability, making them integral components of both generic and branded drug formulations.

Drivers:

1. Surge in Demand for Functional Excipients:

Innovative formulations, especially in controlled-release and targeted drug delivery systems, require specialized excipients that support improved drug efficacy and patient compliance. This trend is boosting demand for high-performance excipients such as co-processed and multifunctional types.

2. Growth in Generic and Biosimilar Markets:

The expiration of patents for several blockbuster drugs is increasing the production of generics and biosimilars, both of which rely on cost-effective and scalable excipient solutions to maintain formulation quality.

3. Expansion of Biopharmaceuticals:

Biopharmaceuticals, such as monoclonal antibodies and protein-based therapies, often demand specific excipients for stabilization, increasing their uptake in the excipient industry.

Restraints:

1. Regulatory and Quality Compliance Challenges:

Stringent regulatory frameworks across global pharmaceutical markets impose strict standards for excipient safety and functionality, adding complexity and cost to development and compliance processes.

2. Raw Material Price Volatility:

Fluctuations in the prices of raw materials used in excipient manufacturing, especially for natural and semi-synthetic polymers, can significantly affect production costs and pricing stability.

Opportunity:

1. Innovations in Oral Drug Delivery:

The growing emphasis on patient-friendly formulations such as orally disintegrating tablets (ODTs), chewables, and taste-masked dosage forms offers significant scope for excipient innovation, especially in pediatrics and geriatrics.

2. Rising Demand from Emerging Markets:

Emerging economies in Asia-Pacific, Latin America, and Africa are rapidly expanding their pharmaceutical manufacturing capabilities, creating lucrative opportunities for excipient suppliers focused on cost-efficiency and scalability.

Market by System Type Insights:

Among the system types, binders and fillers dominated the market in 2023, driven by their extensive use in solid dosage forms like tablets and capsules. These excipients provide essential mechanical strength and ensure uniform drug distribution. The disintegrants segment is expected to grow at the fastest pace, fueled by the trend toward fast-dissolving tablets and immediate-release formulations.

Market by End-use Insights:

Pharmaceutical companies were the largest end users in 2023, holding a majority market share due to their consistent demand for excipients in manufacturing generics and novel therapeutics. Contract Manufacturing Organizations (CMOs) are projected to witness significant growth due to the increasing outsourcing of drug production and formulation development, particularly in cost-sensitive markets.

Market by Regional Insights:

In 2023, North America held the largest share of the global pharmaceutical excipients market, driven by advanced drug development capabilities, strong presence of major pharmaceutical firms, and supportive regulatory infrastructure. However, Asia-Pacific is anticipated to record the highest CAGR during the forecast period due to rapidly growing pharmaceutical production hubs in countries like China and India, along with supportive government initiatives and cost advantages.

Competitive Scenario:

Key players operating in the global pharmaceutical excipients market include:

BASF SE

Ashland Global Holdings Inc.

Dow Chemical Company

Evonik Industries AG

Roquette Frères

Kerry Group

Croda International Plc

Lubrizol Corporation

Colorcon Inc.

Associated British Foods plc

These companies are focusing on product innovation, regional expansion, and strategic collaborations to cater to the evolving needs of pharmaceutical manufacturers. Recent trends include investments in natural excipients, co-processed excipients, and sustainable sourcing practices.

Scope of Work – Global Pharmaceutical Excipients Market

Key Market Developments:

2023: BASF SE expanded its excipient manufacturing capacity in Germany, targeting growing demand for multifunctional and sustainable excipients.

2024: Roquette Frères launched a new range of natural-based excipients for pediatric formulations.

2025: Ashland partnered with a global CMO to develop tailored excipient solutions for complex oral solid dosage forms.

FAQs:

What is the current market size of the Global Pharmaceutical Excipients Market?

The market was valued at USD 9.1 billion in 2023.

What is the major growth driver of the Global Pharmaceutical Excipients Market?

Rising demand for functional excipients in novel drug formulations is a key driver.

Which is the largest region during the forecast period in the Global Pharmaceutical Excipients Market?

North America held the largest share in 2023, while Asia-Pacific is expected to grow the fastest.

Which segment accounted for the largest market share in the Global Pharmaceutical Excipients Market?

The binders and fillers segment dominated by system type, while pharmaceutical companies led by end-use.

Who are the key market players in the Global Pharmaceutical Excipients Market?

Major players include BASF SE, Ashland Global Holdings, Dow, Roquette Frères, and Evonik Industries AG.